Safety and Efficacy of Atezolizumab-Bevacizumab in Real World: The First Indian Experience.

Anand V Kulkarni, Vamsi Krishna,Karan Kumar,Mithun Sharma,Bharat Patodiya,Arif Khan,Sameer Shaik, Ashirwad Pasumarthy, Prateek Chhabra,Pramod Kumar Da,Vivek A Saraswat,Padaki N Rao, Duvvur N Reddy

Journal of clinical and experimental hepatology（2023）

引用 7|浏览12

暂无评分

摘要

Atezolizumab-bevacizumab is safe and effective in uHCC in real-world settings. Candidate selection is of utmost importance in treating uHCC with atezolizumab-bevacizumab to achieve a good response. Current evidence strongly suggests limited use of atezolizumab-bevacizumab in patients with CTP C, and such individuals should not be considered for this combination therapy.

查看译文

关键词

efficacy,atezolizumab-bevacizumab

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要